David Johnson
Director/Board Member bei CARIBOU BIOSCIENCES, INC.
Vermögen: - $ am 31.03.2024
Profil
David L.
Johnson is currently an Independent Director at Caribou Biosciences, Inc. He previously worked as the Vice President-Sales & Marketing at Gilead Sciences, Inc. from 2003 to 2018 and as the Chief Commercial Officer at Global Blood Therapeutics, Inc. from 2018 to 2022.
Mr. Johnson completed his undergraduate degree at the University of Puget Sound and holds an MBA from Kenan-Flagler Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von David Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 11.05.2022 |
Ehemalige bekannte Positionen von David Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2022 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01.01.2018 |
Ausbildung von David Johnson
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
